CN Patent

CN101463081B — 一种glp-1衍生物

Assigned to East China Normal University · Expires 2012-07-04 · 14y expired

What this patent protects

本发明公开一种GLP-1衍生物，其特征在于，该衍生物的分子结构式为以下任何一种结构式：aGLP-1(7-36)即Seq ID No.2；aGLP-1(7-37)即Seq ID No.3；或aGLP-1(7-38)即Seq ID No.4。本发明还公开了GLP-1衍生物的固相化学合成制备方法，以及在制备治疗糖尿病的药物中的用途。

USPTO Abstract

本发明公开一种GLP-1衍生物，其特征在于，该衍生物的分子结构式为以下任何一种结构式：aGLP-1(7-36)即Seq ID No.2；aGLP-1(7-37)即Seq ID No.3；或aGLP-1(7-38)即Seq ID No.4。本发明还公开了GLP-1衍生物的固相化学合成制备方法，以及在制备治疗糖尿病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101463081B
Jurisdiction
CN
Classification
—
Expires
2012-07-04
Drug substance claim
No
Drug product claim
No
Assignee
East China Normal University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.